Offstream
news

COVID-19 pandemic

Cuba initiates its mass vaccination campaign for around 1.7 million people, using its locally-developed SOBERANA 02 and ABDALA vaccines, both of which have yet to complete its Phase III clinical trials.

Sources:  The New York Times